Progyny earnings were $58.5M for the trailing 12 months ending Dec 31, 2025, with 15.3% growth year over year. The latest PGNY earnings report on Dec 31, 2025 announced Q4 2025 earnings of $12.5M, down 9.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PGNY reported annual earnings of $58.5M, with 7.7% growth.
PGNY past earnings growth
How has PGNY's earnings growth performed historically?
On PGNY's earnings call on Invalid Date, Progyny (NASDAQ: PGNY) reported Q4 2025 earnings per share (EPS) of $0.14, up 27.27% year over year. Total PGNY earnings for the quarter were $12.49 million. In the same quarter last year, Progyny's earnings per share (EPS) was $0.11.
As of the last Progyny earnings report, Progyny is currently profitable. Progyny's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $58.52 million, a 7.7% increase year over year.
What was PGNY's earnings growth in the past year?
As of Progyny's earnings date in Invalid Date, Progyny's earnings has grown 15.25% year over year. This is 17.07 percentage points lower than the US Health Information Services industry earnings growth rate of 32.33%. PGNY earnings in the past year totalled $58.52 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.